SLMBP Q1 2026 Earnings EPS Surges Past Expectations as Loan Portfolio Strengthens
Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending
TCRT Q4 2023 Earnings EPS Miss as PreRevenue Biotech Reports Operational Progress
FFIN Q1 2026 Earnings EPS Beats Estimates by 38
VSEC Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction
RenovoRx Inc RNXT Q1 2026 Earnings Wider Loss Per Share Amid PreRevenue ClinicalStage Operations